Eoin Ryan

• Episode 34: Q1 2020 Healthcare Forecast

  10 March 2020

  Episode 34: Q1 2020 Healthcare Forecast 10 March 2020 15:25 Mr. Eoin Ryan Milena Izmirlieva Q1 2020 Healthcare Forecast For our first podcast...

  • Pricing and reimbursement
  • Healthcare Policy
  • Economics & Country Risk

  

• Irish green credentials fail on pharmaceutical waste exports

  02 August 2019

  Life Sciences Irish green credentials fail on pharmaceutical waste exports 02 August 2019 Eoin Ryan Foreign investment in Ireland's pharmaceutical...

  • Sustainability
  • Healthcare Policy

  

• Accuracy check: Norwegian health expenditure data

  29 March 2019

  Life Sciences Accuracy check: Norwegian health expenditure data 29 March 2019 Eoin Ryan The recent publication of Norway's Statistik Sentralbyrå...

  • Healthcare forecasting models

  

• Humira faces up to intense biosimilar competition

  28 November 2018

  Life Sciences Humira faces up to intense biosimilar competition 28 November 2018 Eoin Ryan Praful Mehta The early signs of biosimilar competition...

  • Pricing strategy
  • Pricing and reimbursement

  

• Italian pharma tendering set for new oversight in two-year outlook

  08 October 2018

  Life Sciences Italian pharma tendering set for new oversight in two-year outlook 08 October 2018 Eoin Ryan Italy's public procurement agency...

  • Procurement
  • Pricing strategy
  • Pricing and reimbursement

  

• Norwegian pharma industry calls for tendering and IRP reforms

  05 October 2018

  Life Sciences Norwegian pharma industry calls for tendering and IRP reforms 05 October 2018 Eoin Ryan The pharmaceutical sector in Norway has...

  • Pricing strategy
  • Pricing and reimbursement

  

• UK post-Brexit participation in unified patent court poses plenty of questions

  28 September 2018

  Life Sciences UK post-Brexit participation in unified patent court poses plenty of questions 28 September 2018 Eoin Ryan The UK's future eligibility...

  • Pricing and reimbursement
  • Healthcare Reform
  • Healthcare Policy

  

• On the road to HTA harmonization in Europe

  28 February 2018

  Life Sciences On the road to HTA harmonization in Europe 28 February 2018 Eoin Ryan Last month’s proposals by the European Commission for the...

  • HTA
  • Healthcare Policy

  

• Amsterdam triumphs: Is the Netherlands a Trojan horse for pricing and drug approval reform in Europe?

  28 November 2017

  Life Sciences Amsterdam triumphs: Is the Netherlands a Trojan horse for pricing and drug approval reform in Europe? 28 November 2017 Eoin Ryan...

  • Pricing and reimbursement
  • Market Access
  • Healthcare Policy

  

• Nordics inch toward cooperation on drug purchasing, but don't expect early developments

  13 April 2017

  Life Sciences Nordics inch toward cooperation on drug purchasing, but don't expect early developments 13 April 2017 Eoin Ryan In late March...

  • Pricing and reimbursement
  • Market Access

  

SHOW MORE